Vanguard Group Inc Nemaura Medical Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.32 - $1.14 $1,337 - $4,764	-4,179 Reduced 3.19%	126,682 $40,000
Q4 2022 Feb 10, 2023	BUY	$1.72 - $3.13 $490 - $892	285 Added 0.22%	130,861 $225,000
Q1 2022 May 13, 2022	SELL	$3.78 - $4.66 $7,314 - $9,017	-1,935 Reduced 1.46%	130,576 $570,000
Q4 2021 Feb 14, 2022	SELL	$4.12 - $6.35 $2,257 - $3,479	-548 Reduced 0.41%	132,511 $604,000
Q3 2021 Nov 12, 2021	BUY	$5.76 - $9.95 $4,648 - $8,029	807 Added 0.61%	133,059 $800,000
Q2 2021 Aug 13, 2021	BUY	$4.7 - $16.7 $621,584 - $2.21 Million	132,252 New	132,252 $1.37 Million

Ticker NMRD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,102,900
Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.